Get started
InspireMD Inc.InspireMD Inc.InspireMD Inc.

InspireMD Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

NSPR chart

Key stats

Market capitalization
‪52.78 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.17USD
Net income
‪−19.92 M‬USD
Revenue
‪6.21 M‬USD
Shares float
‪15.70 M‬
Beta (1Y)
2.39

About InspireMD Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Marvin L. Slosman
Website
inspiremd.com
Headquarters
Tel Aviv
Employees (FY)
66
Founded
2005
ISIN
US45779A8466
FIGI
BBG000QDM9D4
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NSPR is 2.21 USD — it has decreased by 1.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange InspireMD Inc. stocks are traded under the ticker NSPR.
InspireMD Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for InspireMD Inc. has a max estimate of 5.20 USD and a min estimate of 4.50 USD.
NSPR earnings for the last quarter are −0.15 USD whereas the estimation was −0.14 USD which accounts for −7.14% surprise. Estimated earnings for the next quarter are −0.20 USD. See more details about InspireMD Inc. earnings.
InspireMD Inc. revenue for the last quarter amounts to ‪1.56 M‬ USD despite the estimated figure of ‪1.50 M‬ USD. In the next quarter revenue is expected to reach ‪1.63 M‬ USD.
Yes, you can track InspireMD Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, NSPR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InspireMD Inc. stock right from TradingView charts — choose your broker and connect to your account.
NSPR reached its all-time high on Jun 1, 2011 with the price of 75862496.00 USD, and its all-time low was 0.81 USD and was reached on Nov 10, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 66.00 employees. See our rating of the largest employees — is InspireMD Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. InspireMD Inc. EBITDA is ‪−20.91 M‬ USD, and current EBITDA margin is −332.88%. See more stats in InspireMD Inc. financial statements.